Skip to content
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the […]
BIO IP Conference looks at academics and perceptions of IP Read More »
We sometimes imagine the inventor of a patent as a lone vanguard leading the charge toward innovation, but in the era of team research
Who invented what? BIO IP panel tackles joint inventorship Read More »
Patents offer the intellectual property protections investors need to support biotech innovation. That’s why the Biotechnology Innovation Organization (BIO) annual IP Council and Committees
BIO 2025 IP Conference: Challenging times for the laws that drive innovation Read More »
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the
National Family Caregivers Month: Recognizing 63 million Americans Read More »
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and runs through Dec. 7. “As patient advocates have seen year
BIO Coffee Chat: Guiding patients through Part D open enrollment Read More »
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates and the biotech industry are working to navigate downstream negative impacts
PACE: Downstream effects of IRA on patients Read More »
The 340B program, in recent decades, has shown how the best laid plans can go sideways when not kept transparent and properly in check.
PACE: How 340B outgrew its goal and stopped helping patients Read More »
The post-COVID era has not been kind to legislation supportive of vaccines, on either the state or the federal level. But advocates have persisted
BIO PACE 2025: Why patient advocates are key to the vaccine conversation Read More »
With the goal of breaking down barriers so patients can access innovative medicines they need, the Biotechnology Innovation Organization (BIO) is bringing patient advocates
BIO brings together patient advocates and industry at PACE Read More »
On the state level, patients are seeing an increasing number of barriers that are making it harder for them to access the therapies they
September Coffee Chat: The State of Patient Access Read More »
